What Is Wrong with Pertussis Vaccine Immunity?

IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human

(2016) S. N. Freiberger et al.   ALLERGY

Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood

(2016) Tara Bancroft et al.   CELLULAR IMMUNOLOGY

Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity Reactions

(2016) Louisa K. James et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma

(2016) J. Christian Virchow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Waning Tdap Effectiveness in Adolescents

(2016) Nicola P. Klein et al.   PEDIATRICS

Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis

(2016) L. Breakwell et al.   PEDIATRICS

Identification of Pertussis-Specific Effector Memory T Cells in Preschool Children

(2015) Lia de Rond et al.   Clinical and Vaccine Immunology

Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases

(2015) Vashti Irani et al.   MOLECULAR IMMUNOLOGY

Pertussis Across the Globe

(2015) Tina Tan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Tdap Vaccine Effectiveness in Adolescents During the 2012 Washington State Pertussis Epidemic

(2015) A. M. Acosta et al.   PEDIATRICS

Modulation of the CD4+ T cell response after acellular pertussis vaccination in the presence of TLR4 ligation

(2015) Jolanda Brummelman et al.   VACCINE

A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

(2015) Manoj Gambhir et al.   PLoS Computational Biology

Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

(2014) S. W. Martin et al.   CLINICAL INFECTIOUS DISEASES

Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012

(2014) A Zeddeman et al.   Eurosurveillance

Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels

(2014) Katherine J L Jackson et al.   IMMUNOLOGY AND CELL BIOLOGY

Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming

(2014) Maria Carollo et al.   VACCINE

Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination

(2013) Rose-Minke Schure et al.   Clinical and Vaccine Immunology

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

(2013) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine

(2013) Pádraig J. Ross et al.   PLoS Pathogens

The Shape of the Lymphocyte Receptor Repertoire: Lessons from the B Cell Receptor

(2013) Katherine J. L. Jackson et al.   Frontiers in Immunology

T-Cell Responses before and after the Fifth Consecutive Acellular Pertussis Vaccination in 4-Year-Old Dutch Children

(2012) Rose-Minke Schure et al.   Clinical and Vaccine Immunology

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

(2012) Sarah L. Sheridan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Immunotherapy for Treatment of Egg Allergy in Children

(2012) A. Wesley Burks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination

(2012) M. Prelog et al.   VACCINE

Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children

(2011) Lotte H. Hendrikx et al.   VACCINE

The role of Th17 cytokines in primary mucosal immunity

(2010) Jay K. Kolls et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins

(2010) Lotte H. Hendrikx et al.   VACCINE

Cellular Immune Responses of Preterm Infants after Vaccination with Whole-Cell or Acellular Pertussis Vaccines

(2009) F. Vermeulen et al.   Clinical and Vaccine Immunology

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content

(2009) Lotte H. Hendrikx et al.   VACCINE

Long-term presence of memory B-cells specific for different vaccine components

(2009) A.M. Buisman et al.   VACCINE

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

(2008) James N. Francis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY